{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:04:30Z","timestamp":1791266670113,"version":"4.1.0"},"reference-count":10,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"DOI":"10.3201\/eid1003.030859","type":"journal-article","created":{"date-parts":[[2012,5,14]],"date-time":"2012-05-14T15:53:52Z","timestamp":1337010832000},"page":"546-547","source":"Crossref","is-referenced-by-count":4,"title":["Migratory Thrombophlebitis and Acute Q Fever"],"prefix":"10.3201","volume":"10","author":[{"given":"Manuel L. Fernandez","family":"Guerrero","sequence":"first","affiliation":[{"name":"Fundacion Jimenez Diaz, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Rivas","sequence":"additional","affiliation":[{"name":"Fundacion Jimenez Diaz, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa Garcia","family":"Delgado","sequence":"additional","affiliation":[{"name":"Fundacion Jimenez Diaz, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1822","published-online":{"date-parts":[[2004,3]]},"reference":[{"key":"key-10.3201\/eid1003.030859 -201205140400-R1","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1128\/CMR.6.3.193","article-title":"Q fever.","volume":"6","author":"Reimer","year":"1993","journal-title":"Clin Microbiol Rev"},{"key":"key-10.3201\/eid1003.030859 -201205140400-R2","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.3201\/eid0909.030086","article-title":"Q fever in Thailand.","volume":"9","author":"Supputtamongkol","year":"2003","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid1003.030859 -201205140400-R3","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1097\/00005792-200003000-00005","article-title":"Q fever 1985 to1998. Clinical and epidemiologic features of 1,383 infections.","volume":"79","author":"Raoult","year":"2000","journal-title":"Medicine (Baltimore)"},{"key":"key-10.3201\/eid1003.030859 -201205140400-R4","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1086\/323031","article-title":"Atypical manifestations of chronic Q fever.","volume":"33","author":"Hatchette","year":"2001","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid1003.030859 -201205140400-R5","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/ajcp\/112.2.159","article-title":"Hemostatic changes in Rocky Mountain spotted fever and Mediterranean spotted fever.","volume":"112","author":"Elghetany","year":"1999","journal-title":"Am J Clin Pathol"},{"key":"key-10.3201\/eid1003.030859 -201205140400-R6","first-page":"151","article-title":"Fiebre Q y tromboembolismo pulmonar.","volume":"187","author":"Cuenca","year":"1990","journal-title":"Rev Clin Esp"},{"key":"key-10.3201\/eid1003.030859 -201205140400-R7","first-page":"396","article-title":"Tromboflebitis e un paciente con fiebre Q aguda y anticuerpos anticardiolipina.","volume":"108","author":"G\u00e1lvez","year":"1997","journal-title":"Med Clin (Barc)"},{"key":"key-10.3201\/eid1003.030859 -201205140400-R8","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0213-005X(01)72588-8","article-title":"Tromboembolismo pulmonar en paciente con fiebre Q \u00bf son los anticuerpos anticardiolipina la causa?","volume":"19","author":"Del Arco","year":"2001","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"key-10.3201\/eid1003.030859 -201205140400-R9","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/clinids\/18.2.213","article-title":"Prevalence, significance, and specificity of antibodies to phospholipids in Q fever.","volume":"18","author":"Ordi Ros","year":"1994","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid1003.030859 -201205140400-R10","doi-asserted-by":"publisher","first-page":"4120","DOI":"10.1073\/pnas.87.11.4120","article-title":"Anti-phospholipids antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: \u03b22-glycoprotein I (apolipoprotein H).","volume":"87","author":"McNeil","year":"1990","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/10\/3\/03-0859_article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T02:47:50Z","timestamp":1732589270000},"score":1,"resource":{"primary":{"URL":"http:\/\/wwwnc.cdc.gov\/eid\/article\/10\/3\/03-0859_article.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3]]},"references-count":10,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2004,3]]}},"URL":"https:\/\/doi.org\/10.3201\/eid1003.030859","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,3]]}}}